Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05766761 · ClinicalTrials.gov registry record · NA

Reducing Alcohol Exposed Pregnancies

A NA study of Alcohol Drinking, sponsored by New York University.

Recruiting
Registry status
NA
Development phase
600
Enrollment target
1
Study location

NCT05766761: Recruiting NA study of Alcohol Drinking, sponsored by New York University.

NCT05766761 is a NA study of Alcohol Drinking that is actively recruiting participants, run by New York University. The registered enrollment target is 600 participants, roughly in line with the 623-participant average among 85 other Alcohol Drinking trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05766761, a NA study of Alcohol Drinking, is actively recruiting participants, sponsored by New York University.

RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to compare an active intervention versus a standard of care control in reducing alcohol use among pregnant women. The main questions it aims to answer are whether a motivational intervention can: 1. increase the proportion of women detected with a laboratory-confirmed negative phosphatidylethanol (PEth) test during pregnancy, and 2. reduce the proportion of adverse birth outcomes among infants. Participants will be offered (1) a self-paced computer-delivered alcohol reduction intervention to enhance knowledge, norms, and motivation for alcohol reduction and (2) a nurse-delivered component to reinforce the computer-delivered content and address women's questions. Both components are theory-driven, based on Motivational Enhancement Theory (MET), and use motivational strategies to promote alcohol reduction.

Primary Outcome

Proportion of women detected with a laboratory-confirmed negative PEth test during pregnancy

Conditions Studied

Interventions

  • BEHAVIORAL Intervention condition, the usual prenatal care plus the alcohol intervention

Study Locations (1)

Texas

  • The University of Texas Health Science Center, Houston - Houston

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2024-04-15
Est. Completion 2027-04-30
Phase NA
New York University

83 total trials

What NCT05766761 shows while recruiting

NCT05766761 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 623-participant average among 85 other Alcohol Drinking trials with a reported enrollment target.

The record links to 1 condition, with Alcohol Drinking appearing as the primary indexed condition, and to 1 intervention - of which Intervention condition, the usual prenatal care plus the alcohol intervention is the first listed.

NCT05766761 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05766761 about?

NCT05766761 is a clinical study titled "Reducing Alcohol Exposed Pregnancies". The goal of this clinical trial is to compare an active intervention versus a standard of care control in reducing alcohol use among pregnant women. The main questions it aims to answer are whether a motivational intervention can: 1. increase the proportion of women detected with a laboratory-confi...

What is the current status of trial NCT05766761?

This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2024-04-15. Estimated completion is 2027-04-30.

What conditions does trial NCT05766761 study?

This clinical trial studies the following conditions: Alcohol Drinking.

What interventions are being tested in trial NCT05766761?

The interventions under investigation include: Intervention condition, the usual prenatal care plus the alcohol intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05766761?

This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05766761 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Drinking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05766761's enrollment target sits among peer trials

600 17th of 85 higher than 68 of 85 other Alcohol Drinking trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alcohol Drinking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05766761, the US trial registry maintained by the National Library of Medicine. NCT05766761 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.